Health funding

MiiHealth AI is a startup focused on developing AI-driven solutions for patient intake processes. The company aims to streamline healthcare operations by enhancing the efficiency of patient onboarding. This funding round will help MiiHealth AI scale its technology and reach more healthcare providers.

Khartis is a biopharmaceutical company focused on developing innovative oral therapies. The company aims to provide effective alternatives to existing treatments, specifically targeting conditions treated by Tepezza. This funding round will support their efforts in advancing their oral challenger to Tepezza.

InduPro is a biotechnology company focused on defining membrane protein spatial relationships to create novel therapeutics for cancer and autoimmune diseases. The company is advancing its lead oncology program, IDP-001, which is currently in a Phase 1 clinical study targeting advanced squamous non-small cell lung cancer and other solid tumors. This funding round will support the clinical development and proof-of-concept data generation for IDP-001.

Wondermind is a mental health company focused on providing resources and support for mental well-being. It aims to empower individuals to take charge of their mental health through innovative solutions. The recent funding round highlights the interest in mental health startups, especially those associated with well-known figures like Selena Gomez.

Whoop is a wearable technology company that specializes in fitness tracking devices. It targets health-conscious consumers looking for data-driven insights into their fitness and recovery. The company recently raised $575 million in Series G funding, making it the largest funding round in the fitness and wellness sector this year.

Aligned Marketplace is a startup that connects self-insured employers with primary care clinics. The company aims to streamline access to healthcare for employers and their employees, making primary care more accessible and efficient.

Mediwhale is an AI-powered healthcare startup that has developed a non-invasive retina scanning technology to diagnose various health conditions, including cardiovascular and kidney disorders. The company targets patients at risk of developing these conditions, aiming to provide early detection and treatment options.

August AI is a healthtech startup focused on leveraging artificial intelligence to improve healthcare outcomes. The company aims to provide innovative solutions that enhance patient care and streamline healthcare processes. This funding round will support their growth and development in the healthtech sector.

Zac Altman's new startup focuses on providing solutions for individuals with ADHD. The company aims to address the unique challenges faced by this demographic, leveraging innovative approaches to improve their quality of life.

Vaderis is a biotechnology company focused on developing treatments for rare diseases, specifically hereditary hemorrhagic telangiectasia (HHT). The company has recently closed a $152 million Series B financing round to support the advancement of its investigational therapy, engasertib, which targets the underlying causes of HHT. This funding will enable Vaderis to conduct a Phase III clinical trial for this promising treatment option.

Arab Therapy is a platform that connects users with mental health professionals across the Middle East. The company aims to provide accessible mental health support to individuals in the region, addressing a growing need for such services. This funding round will help expand their reach and enhance their offerings.

Epicrispr is focused on developing epigenetic editing therapies for rare muscle diseases. The company aims to leverage its innovative technology to address unmet medical needs in this niche market. The recent funding will help advance their drug development efforts.

K2 Therapeutics is a Singapore-based biotech company focused on developing innovative therapies. The company has recently secured a significant seed funding round to advance its research and development efforts. This funding will support their mission to create impactful solutions in the healthcare sector.

Ayati Devices is a MedTech startup focused on developing innovative diagnostic platforms. The company aims to enhance healthcare accessibility and efficiency through its technology. This funding round will support their expansion efforts.

Curecreteconnect is a company that has been acquired by Apollo Hospitals. The acquisition signifies Apollo's expansion into new health services. The deal is valued at ₹1,200 crore, highlighting the strategic growth of Apollo Hospitals in the healthcare sector.

StairMed is a company focused on advancing stent-like brain-computer interface (BCI) implants. The company aims to innovate in the medical technology space, particularly in neurology, by developing advanced implantable devices. This funding round will support their research and development efforts.

StrongRoom AI is an Australian startup that specializes in controlled-substance management, helping regulated organizations manage the distribution of substances like fentanyl and medical cannabis. The company recently raised $2 million to fund product development and customer growth, following a significant turnaround after its acquisition out of administration.

Entera Bio Ltd. is a biotechnology company focused on developing oral drug delivery systems for biologics. The company aims to improve patient compliance and expand the market for biologic therapies. The recent financing will support a pivotal Phase 3 trial for its lead product, EB613.

Claryx is focused on tracking patient infections in hospitals. Their technology aims to improve patient outcomes and reduce healthcare costs by providing real-time data on infection rates. This funding round will help them enhance their platform and expand their market reach.

Healia is a health benefits startup that aims to reduce out-of-pocket healthcare costs for dual-income families. The company provides a platform that allows employers to cover employees' out-of-pocket costs when they choose to enroll in a spouse's health plan, addressing a significant gap in traditional employer benefits.

Vexev is a medical technology startup that has developed an automated ultrasound platform for vascular imaging. The company aims to enhance the availability of high-quality vascular imaging for patients, particularly in dialysis care. This funding round will support regulatory clearance and clinical application of their technology.

Alkeus Pharmaceuticals is a biotechnology startup focused on developing a treatment for Stargardt disease, a genetic condition that leads to progressive vision loss. The company is notable for its innovative drug, gildeuretinol, which has shown promise in clinical trials and is now being acquired by Tarsus Pharmaceuticals for up to $800 million.

HealthSnap is a healthtech company that provides a virtual-care platform designed to keep patients connected to their care teams beyond traditional office visits. The company focuses on improving health outcomes through continuous monitoring and AI integration, serving over 80,000 patient programs across various health systems.

Expedition Therapeutics is a biotechnology company focused on developing innovative therapies for chronic obstructive pulmonary disease (COPD). The company is notable for its lead therapy, EXPD-101, which targets inflammation in the lungs, aiming to intervene earlier in the disease process rather than just alleviating symptoms. The recent $115 million Series B financing will support the launch of a global Phase 2 clinical trial for this treatment.

Attovia Therapeutics is a clinical-stage biopharmaceutical company focused on developing next-generation therapies for immune-mediated diseases. The company holds an exclusive global license to the ATTOBODY biologics platform, which enables the rapid generation of diverse candidate molecules. Attovia has already nominated three product candidates and aims to advance their clinical development with proceeds from their recent IPO.

QuantHealth develops AI-based simulations for clinical trials, helping drugmakers test decisions before enrolling patients or committing significant capital. The company aims to improve the efficiency and success rates of clinical trials, which are often costly and uncertain.

Dash Bio is a company focused on drug development, positioning itself as the 'Amazon Web Services of drug development'. This funding round will help enhance its capabilities in the biotech sector.

Thoughtful Automation Inc. is a healthcare revenue cycle management startup that focuses on automating revenue collection processes. The company aims to improve efficiency in healthcare billing by utilizing AI agents designed to handle complex tasks such as claims processing and patient eligibility verification. This funding round will help accelerate their business and expand their innovative solutions in the healthcare sector.

Procode AI specializes in AI-powered revenue cycle management (RCM) specifically for surgical billing. The company aims to streamline billing processes in the healthcare sector, making it more efficient and accurate. This funding round will help Procode AI enhance its technology and expand its market reach.

Xeltis is a commercial-stage MedTech company developing artificial vessels and valves that are gradually replaced by patients’ own living healthy tissue. The company aims to improve patient outcomes in hemodialysis vascular access and cardiovascular replacements, addressing significant unmet needs in these areas.

DITTO is a female-led startup focused on menstrual health. The company aims to provide innovative solutions for menstrual care, addressing the unique needs of women. This funding round will help them expand their product offerings and reach more customers.

Navi is a paediatric medtech company focused on developing innovative solutions for children's health. The company aims to improve healthcare outcomes for young patients through advanced technology. This funding round will help accelerate their product development and market reach.

Dopl is a Seattle-area startup focused on developing a remotely operated robotic ultrasound system. The company aims to expand access to ultrasound technology in rural and underserved communities, seeking FDA clearance for its innovative platform.

Flourish Health provides intensive mental healthcare services for youth. The company aims to address the growing need for accessible mental health support among young people, making it a notable player in the mental health sector. This funding will help scale their operations to reach more individuals in need.

DoctorBook is a Syrian health tech startup that digitizes medical appointments through an online platform connecting patients with healthcare providers. The platform allows clinics to manage bookings, patient flow, and medical records, enhancing efficiency for both patients and doctors.

Casana is a health tech startup that develops smart toilet seats equipped with sensors to monitor vital health metrics such as blood pressure and heart rate. Targeting health-conscious consumers, the company aims to simplify health tracking by integrating it into daily routines without requiring behavioral changes.

Medyria is a Swiss medical technology pioneer specializing in invasive coronary diagnostics. The company develops blood-flow-velocity sensors and catheter technologies, with its lead product, PyCath, designed to measure blood flow velocity during interventional cardiology procedures.

Elle, MD Technologies is a Nova Scotia-based medtech startup focused on developing non-hormonal contraceptive devices. Their flagship product, Livv, is a vaginal contraceptive ring designed to provide birth control without the side effects associated with hormonal methods. The recent funding will support their first human clinical trial at The Ottawa Hospital.

The American Baby Company is a fertility startup focused on providing affordable IVF services. It aims to make IVF accessible to more couples struggling with infertility by offering a full IVF cycle for $8,995, significantly lower than the average cost in the U.S. The company is opening its first clinic in West Palm Beach, Florida.

Transcripta Bio is an AI-driven drug discovery startup focused on developing small molecule therapeutics to modulate gene expression disease signatures. The company aims to advance IND-enabling studies and clinical preparation for neurological diseases, including autism spectrum disorder and muscular dystrophy. Their innovative approach leverages robotic platforms and AI models to enhance drug discovery success rates.

Assured Health is focused on streamlining the process for healthcare providers to get in-network with insurance companies. By leveraging Agentic AI, the company aims to enhance efficiency and reduce the time it takes for providers to join networks, ultimately improving patient access to care.

CARPL.ai is a healthtech startup that focuses on leveraging artificial intelligence to improve healthcare outcomes. The company aims to provide innovative solutions that enhance patient care and streamline healthcare processes. This funding round will help accelerate their growth and development of their technology.

Elle MD is developing a non-hormonal, easily removable birth control ring. The company targets women seeking alternative contraceptive methods that do not involve hormones, making it a distinctive option in the market.

Tikva Allocell is focused on developing engineered EBV-specific T-cell therapies aimed at treating solid tumors. The company is advancing innovative treatments that leverage the immune system to target cancer cells more effectively.

Cheiron is an AI biotech startup that has developed a generative AI platform for drug development. It targets the biopharma market by providing a comprehensive operating system that integrates various data sources to support drug developers. The recent funding will help expand its capabilities and enhance its Life Sciences Knowledge Graph.

Brenus Pharma is a Lyon-based clinical-stage biotech startup focused on preventing cancer recurrence through innovative immunotherapy solutions. The company is developing a platform that engages the immune system to target hard-to-treat solid tumors, utilizing a novel dendritic cell-engager modality to convert cold tumors into responsive ones. This funding will help advance their next drug candidate and complete their Phase I program.

Bioscan Research is a medtech startup that leverages deeptech in optics, electronics, mechanics, and software to improve outcomes for traumatic brain injury patients. Their flagship product, CEREBO, is an advanced intra-cranial injury detector designed for early detection of brain injuries, even in the absence of visible symptoms.

N-Zyme Biomedical is focused on developing novel therapies for reflux disease, specifically through its pepsin inhibitor platform. The company aims to address significant unmet medical needs in conditions like laryngopharyngeal reflux and gastroesophageal reflux disease. This funding round will accelerate their Phase 2 clinical programs and further their innovative approach to treatment.

Karoo Health is a startup focused on cardiovascular technology. The company aims to innovate in the health sector, particularly in solutions related to heart health. This funding round will help accelerate their growth and development efforts.

Even Healthcare offers subscription-based healthcare services and insurance, allowing users to access their in-house team of doctors for virtual and in-clinic consultations, diagnostics, and other tests. The company is expanding its hospital network and currently covers around 50,000-60,000 members in Bengaluru and 200,000-300,000 patients across India.